Concepedia

Mark E. Bangs

ME

19

Publications

829

Citations

15

H-Index

1994

Active since

Affiliations

Eli Lilly (United States)(Current)

Indiana University School of Medicine

Indiana University – Purdue University Indianapolis

Baylor College of Medicine

Mark E. Bangs is an author at Eli Lilly (United States) specializing in medicine, psychiatry, and social sciences.

Top concepts

Publications per year

1994–2022

19

Publications

19

A Double-Blind Efficacy and Safety Study of Duloxetine Fixed Doses in Children and Adolescents with Major Depressive Disorder

Graham J. Emslie, Apurva Prakash, Qi Zhang et al. · Journal of Child and Adolescent Psychopharmacology · 2014 · 105 citations · Full text

Seizure risk in patients with attention‐deficit‐hyperactivity disorder treated with atomoxetine

Joachim Wernicke, Karen C. Holdridge, Ling Jin et al. · Developmental Medicine & Child Neurology · 2007 · 89 citations · Full text

Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder

Mark E. Bangs, Philip Hazell, Marina Danckaerts et al. · PEDIATRICS · 2008 · 80 citations

A Double-Blind Efficacy and Safety Study of Duloxetine Flexible Dosing in Children and Adolescents with Major Depressive Disorder

Sarah Atkinson, Apurva Prakash, Qi Zhang et al. · Journal of Child and Adolescent Psychopharmacology · 2014 · 77 citations

Hepatic Events Associated with Atomoxetine Treatment for??Attention-Deficit??Hyperactivity Disorder

Mark E. Bangs, Ling Jin, Shuyu Zhang et al. · Drug Safety · 2008 · 66 citations

, , +9

Rows per page

1–5 of 19